Cybin Inc. (HELP)
NASDAQ: HELP · Real-Time Price · USD
5.70
+0.20 (3.64%)
Apr 20, 2026, 11:28 AM EDT - Market open
Cybin Market Cap
Cybin has a market cap or net worth of $285.2 million as of April 20, 2026. Its market cap has increased by 116.58% in one year.
Market Cap
285.20M
Enterprise Value
80.07M
1-Year Change
116.58%
Ranking
Category
Stock Price
$5.70
Market Cap Chart
Since November 11, 2020, Cybin's market cap has increased from $91.10M to $285.20M, an increase of 213.08%. That is a compound annual growth rate of 23.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 275.20M | -32.58% |
| Dec 31, 2025 | 408.21M | 131.40% |
| Dec 31, 2024 | 176.41M | 4.62% |
| Dec 29, 2023 | 168.63M | 199.71% |
| Dec 30, 2022 | 56.26M | -72.57% |
| Dec 31, 2021 | 205.14M | 4.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Minerva Neurosciences | 295.06M |
| Protara Therapeutics | 294.22M |
| Polaryx Therapeutics | 289.74M |
| C4 Therapeutics | 284.93M |
| Alector | 283.63M |
| Achieve Life Sciences | 271.52M |
| SAB Biotherapeutics | 270.56M |
| Orchestra BioMed Holdings | 268.03M |